These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6061062)

  • 1. [Antisecretory therapeutic activity of Milid (xylamide, CR 242) in the treatment of gastroduodenal ulcer].
    Giordano G; Comi L
    Minerva Med; 1967 Oct; 58(86):3688-91. PubMed ID: 6061062
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical considerations on the therapeutic effect of a new non-anticholinergic antisecretory preparation: Milid (xylamide, CR 242)].
    Castelli CA; Locatelli L; Salvioni GF
    Minerva Med; 1967 Oct; 58(86):3704-8. PubMed ID: 6061065
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological and clinical studies of a non-anticholinergic antisecretory product: Milid (xylamide, CR 242)].
    Mainoli S; Milvio C; Borellini D
    Minerva Med; 1967 Oct; 58(86):3708-12. PubMed ID: 6061066
    [No Abstract]   [Full Text] [Related]  

  • 4. [Signs of tolerability in man, clinical pharmacology and activity of a new non-anticholinergic product active in gastroduodenitis and gastroduodenal ulcer (Milid)].
    Casone A; Borellini D; Jezzi B
    Minerva Med; 1967 Oct; 58(86):3699-704. PubMed ID: 6061064
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation, in gastritis and gastroduodenal ulcers of a new non-anticholinergic compound with protective and antisecretory activity].
    Fantino M; Roccia L
    Minerva Med; 1967 Oct; 58(86):3677-85. PubMed ID: 6061061
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of some conditions of chronic gastroduodenitis and of gastroduodenal ulcer with a preparation, for intravenous or intramuscular injection or oral administration, derived from a carboxyl halicyclic acid].
    Abbona C; Gatto PL; Bezante GC
    Minerva Med; 1967 Oct; 58(86):3691-9. PubMed ID: 6061063
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gastroprotective activity of a new substance (xylamide, Milid) in gastric disorders secondary to administration of corticoids].
    Gobbi F
    Minerva Med; 1967 Oct; 58(86):3685-8. PubMed ID: 5183197
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of peptic ulcer with xylamide (preliminary note; analysis of 18 cases)].
    de Carvalho PR; Penteado JF; Zacharias N
    Rev Bras Med; 1969 Oct; 26(10):606-15. PubMed ID: 5404871
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacology and experimental toxicology of a new non-anticholinergic product with antisecretory and gastroprotective activity (CR 242, xylamide-Milid)].
    Rovati AL; Casula PL; Da Re G
    Minerva Med; 1967 Oct; 58(86):3656-70. PubMed ID: 6061059
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aluminium glycyrrhetate in the therapy of gastroduodenal peptic ulcer and of other gastroduodenal diseases].
    Fontana G; Faggioli F
    Minerva Med; 1969 Feb; 60(17):745-60. PubMed ID: 5776059
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of gastroduodenal ulcer with Condrovister].
    Guillén G; Muñoz JR; Pastor L
    Folia Clin Int (Barc); 1965 May; 15(5):241-68. PubMed ID: 4221041
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic effect of a new antisecretory and anti-acid drug].
    Galli L; Bissi A
    Rev Bras Gastroenterol; 1967; 19(3):43-9. PubMed ID: 4387428
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic effect of a new antisecretory and antacid medication].
    Galli L; Bissi A
    Minerva Chir; 1968 May; 23(9):477-82. PubMed ID: 4386093
    [No Abstract]   [Full Text] [Related]  

  • 14. [U factor in the treatment of gastroduodenal ulcers].
    Siffert Júnior G
    Rev Bras Med; 1969 Feb; 26(2):123-6. PubMed ID: 5790652
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with CR-242, Xylamide, in the treatment of gastroduodenal ulcerous disease. Study of 30 cases].
    Arias Vallejo E; Diaz G; Moreno Arranz B; Lozano L
    Minerva Med; 1969 Mar; 60(23):1057-62. PubMed ID: 5781333
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of peptic ulcer using antacids and anxiolytic agents. Results after prolonged treatment].
    Michetti P; De Conca V
    Clin Ter; 1976 Sep; 78(5):463-9. PubMed ID: 12908
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of gastroduodenal ulcers with a new anti-inflammatory and cicatrizing agent].
    Alcalde Gonzalez DR
    Rev Esp Enferm Apar Dig; 1966 Nov; 25(9):1052-68. PubMed ID: 5997897
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of peptic ulcer with an antacid chelate, calcium glucaldrate].
    San Juan F; Treiger M; Abrahão LJ; Macedo R; Chor S
    Hospital (Rio J); 1965 Sep; 68(3):575-83. PubMed ID: 5295102
    [No Abstract]   [Full Text] [Related]  

  • 19. [A new cicatrizing, antivagal and antacid association in the therapy of gastroduodenal ulcer].
    Falcone F
    Minerva Med; 1969 Feb; 60(17):738-44. PubMed ID: 4887321
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of the therapeutic activity of CR 242 or Xylamide in the treatment of gastric and duodenal ulcers and of gastroduodenitis].
    Bellomo A; Strobbia R; Manzoni A
    Minerva Med; 1969 Mar; 60(23):1024-31. PubMed ID: 5781328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.